Australian people can buy antibiotics in Australia online here: http://buyantibioticsaustralia.com/ No prescription required and cheap price!

Microsoft word - april 2009 detailed formulary.doc

2009 Detailed Formulary
April 2009
INTRODUCTION
This Member Formulary is a useful aid to understanding your drug benefit program. The formulary is a list of drugs reviewed and
approved by an independent committee of physicians and pharmacists. The formulary includes drugs that are commonly prescribed by
physicians, clinically useful, and cost-effective.
Bring this Member Formulary to your doctor appointments. Your doctor can review the formulary and determine if a drug listed isappropriate for you. When you have a prescription filled, your copayment will be at one of three levels or "tiers." Tier 1 and tier 2 drugswill be the lower copayments. However, a tier 1 or tier 2 drug may not always be available or the best choice for your medical condition.
Tier 1 (lowest copayment) includes only generic versions of brand-name drugs. Generic drugs are noted in lowercase type. A brand-
name drug that is bolded indicates that a generic is available. All generic drugs, whether listed in this formulary or not, are the lowest
copayment.
Tier 2 (intermediate copayment) includes selected brand-name drugs. Brand-name drugs are noted in all capital letters.
Tier 3 (highest copayment) includes all brand-name drugs not listed in tier 2 and includes all brands not listed in this formulary.
Brand-name drugs are shown in capital letters. Those with generic versions available are identified with a bolded brand name.
Generic versions of brand-name drugs are always in tier 1 (lowest copayment.)

The drug names listed here are the registered and/or unregistered trademarks of third-party pharmaceutical companies unrelated toand unaffiliated with Script Care. These trademarked brand names are included here for informational purposes only and are notintended to imply or suggest any affiliation between Script Care and such third-party pharmaceutical companies.
LEARNING MORE ABOUT GENERIC DRUGS
One way you can reduce your out-of-pocket cost is by requesting a generic drug. A generic drug is a copy of the original brand-name
drug, whether prescription or over-the-counter. Generic drugs are usually priced lower than their brand-name equivalents.
Generic drugs are:

Approved by the U.S. Food and Drug Administration for safety and effectiveness, and are manufactured under the same strictstandards which apply to brand-name drugs.
Tested in humans to assure the generic is absorbed in the bloodstream in a similar manner as the brand-name drug. Generics maybe different from the brand in size, color, and inactive ingredients, but this does not alter the effectiveness or the ability to beabsorbed just like the brand-name drug.
Manufactured in the same strength and dosage form as the brand-name drug.
When a generic drug is substituted for a brand-name drug, you can expect the generic to produce the same clinical effect and
safety profile as the brand-name drug.

HELPFUL HINTS FOR TAKING DRUGS PROPERLY

Consult your pharmacist when you have questions about prescription and over-the-counter drugs.
Take your medication exactly as prescribed.
Store your medication at room temperature unless advised differently on the label.
Display the telephone number of your local Poison Control Center on your phone.
Keep an up-to-date list of your prescription and over-the-counter drugs, including the dosage schedule and the name of theprescribing physician, in your purse or wallet. Every time you have an appointment, show the list to your doctor.
IMPORTANT
Your benefit coverage may not be limited to this list. There may be drugs listed here that are not covered by your specific plan. Some
strengths/dosage forms of drugs listed may not be on the formulary. Using this list is voluntary. This list is subject to change at any time.
Refer to your benefit materials or call your prescription benefit member services telephone number for specific coverage information.

Only the dosage forms/strengths of the brand-name product noted are on the Member Formulary
Only the brand-name product noted is on the Member Formulary
Boldface
Indicates generic availability; boldface may not apply to every strength or dosage form under the listed generic name delayed-rel Delayed-release (also known as enteric-coated), refer to the reference brand listed for clarification
ext-rel
Extended-release (also known as sustained-release), refer to the reference brand listed for clarification ANALGESICS
Practice guidelines of pain management are colchicine tabs
available at: http://www.asahq.org
probenecid
ZYLOPRIM
diflunisal
etodolac
NARCOTIC ANALGESICS
indomethacin
DILAUDID
nabumetone
Management (includes WHO analgesic ladder) DURAGESIC
salsalate
are available at: http://www.asahq.org
MS CONTIN
http://www.nccn.org/professionals
Opioid guidelines in the management of chronic PERCOCET
CLINORIL
ROXICODONE
http://www.asipp.org/Guidelines.htm
INDOCIN SR
NON-NARCOTIC ANALGESICS
FIORICET
MAXIDONE
FIORINAL
NAPROSYN
VOLTAREN
TYLENOL w/CODEINE
VICODIN ES

VISCOSUPPLEMENTS
COX-2 INHIBITORS
NARCOTIC ANALGESICS, CII
morphine
morphine supp
oxycodone soln
ANTI-INFECTIVES
Hepatitis: CDC recommendations on the
Sulfonamides
http://www.cdc.gov/ncidod/diseases/hepatiti
s/index.htm
Second Generation
hepatitis by the American Association for the Tetracyclines
http://www.aasld.org
tetracycline
HIV/AIDS: Guidelines for the treatment of HIV
Third Generation
patients by the U.S. Department of Health and http://www.aidsinfo.nih.gov
PERIOSTAT
Infective Endocarditis: American Heart
VIBRAMYCIN
Association recommendations for theprevention of bacterial endocarditis are Erythromycins/Macrolides
ANTIFUNGALS
available at: http://www.americanheart.org
Influenza: Recommendations of the Advisory
erythromycin delayed-rel
erythromycin stearate
http://www.cdc.gov/ncidod/diseases/flu/fluvi
DIFLUCAN
BIAXIN XL
LAMISIL #
International Travel: CDC recommendations
for international travel are available at: PEDIAZOLE
MYCOSTATIN
http://www.cdc.gov/travel
ZITHROMAX
Sexually Transmitted Diseases: CDC
SPORANOX
Sexually Transmitted Diseases Guidelines are Fluoroquinolones
ANTIMALARIALS
http://www.cdc.gov/std/treatment/2006/clinic
Respiratory Tract Infection/Antibiotic
Use/Community Acquired Pneumonia/Other:
Principles of appropriate antibiotic use for CIPRO tabs
treatment of nonspecific upper respiratory tract infection in adults are available at:
http://www.cdc.gov/drugresistance/communi
Antiretroviral Combinations
Penicillins
ty/healthcare_provider.htm
Practice guidelines and statements developed ampicillin
dicloxacillin
http://www.idsociety.org
penicillin VK
ANTIBACTERIALS
Cephalosporins
AUGMENTIN
Chemokine Receptor Antagonists
First Generation
AUGMENTIN ES-600
AUGMENTIN XR
Protease Inhibitors
REBETOL caps
Fusion Inhibitors
Herpes Agents
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase
Influenza Agents
Inhibitors
ANTITUBERCULAR AGENTS
amantadine
isoniazid
pyrazinamide
MYAMBUTOL
FLUMADINE
Nucleoside Reverse Transcriptase
MISCELLANEOUS
Inhibitors
ANTIVIRALS
Cytomegalovirus Agents
mebendazole
trimethoprim
ganciclovir
RETROVIR
Hepatitis Agents
Nucleotide Reverse Transcriptase
MACROBID
Inhibitors
MACRODANTIN
ANTINEOPLASTIC AGENTS
Clinical practice guidelines in oncology are available at: http://www.nccn.org
http://www.asco.org
ALKYLATING AGENTS
Antiestrogens
KINASE INHIBITORS
cyclophosphamide
tamoxifen
Aromatase Inhibitors
ANTIMETABOLITES
TOPOISOMERASE INHIBITORS
Luteinizing Hormone-releasing
Hormone (LHRH) Agonists
MISCELLANEOUS
PURINETHOL
HORMONAL ANTINEOPLASTIC
VESANOID
Antiandrogens
Progestins
flutamide
HYDREA
VEPESID

CARDIOVASCULAR
Guidelines for the evaluation and management Committee on Prevention, Detection, Evaluation http://www.nhlbi.nih.gov/guidelines/hyperten
http://www.acc.org
Guidelines for the use of angiotensin II receptor PRAVACHOL
http://www.americanheart.org
antagonists in various patient populations are http://www.hfsa.org
available at: http://www.diabetes.org
ACE INHIBITORS
http://www.nhlbi.nih.gov/guidelines/hyperten
Niacins/Combinations
Guidelines for the use of ACE inhibitors are http://www.acc.org
ATACAND *
http://www.americanheart.org
http://www.diabetes.org
http://www.nhlbi.nih.gov/guidelines/hyperten
BETA-BLOCKERS
Guidelines for the use of beta-blockers and beta-blocker combinations in various patient ACCUPRIL
http://www.acc.org
http://www.nhlbi.nih.gov/guidelines/hyperten
LOTENSIN
pindolol
MONOPRIL
* Atacand should be reserved for patients who meet CHARM (Candesartan in Heart Failure - ACE INHIBITOR/CALCIUM
CHANNEL BLOCKER
ANTIARRHYTHMICS
COMBINATIONS
Guidelines for the use of antiarrhythmics and INDERAL LA
LOPRESSOR
http://www.acc.org
TENORMIN
TRANDATE
mexiletine
ACE INHIBITOR/DIURETIC
COMBINATIONS
BETA-BLOCKER/DIURETIC
COMBINATIONS
ACCURETIC
BETAPACE
Guidelines for the use of beta-blockers and CAPOZIDE
BETAPACE AF
LOTENSIN HCT
CORDARONE
MONOPRIL-HCT
http://www.acc.org
VASERETIC
NORPACE CR
http://www.nhlbi.nih.gov/guidelines/hyperten
ZESTORETIC
ADRENOLYTICS, CENTRAL
TAMBOCOR
LOPRESSOR HCT
TENORETIC
CATAPRES
ANTILIPEMICS
Guidelines for the use of antilipemics in various CALCIUM CHANNEL BLOCKERS
http://www.nhlbi.nih.gov
Dihydropyridines
ALDOSTERONE RECEPTOR
Bile Acid Resins
ANTAGONISTS
ADALAT CC
ALDACTONE
COLESTID
PROCARDIA XL
QUESTRAN/QUESTRAN LIGHT
ALPHA BLOCKERS
Nondihydropyridines
Cholesterol Absorption Inhibitors
Guidelines for the use of alpha blockers in various patient populations are available at: http://www.nhlbi.nih.gov/guidelines/hyperten
CARDIZEM CD
Fibrates
CARDURA
HYTRIN

CALCIUM CHANNEL
BLOCKER/ANTILIPEMIC
ANGIOTENSIN II RECEPTOR
COMBINATIONS
ANTAGONIST/CALCIUM CHANNEL
BLOCKER COMBINATIONS
HMG-CoA Reductase Inhibitors
DIGITALIS GLYCOSIDES
digoxin ped elixir
ANGIOTENSIN II RECEPTOR
ANTAGONISTS/DIURETIC
COMBINATIONS
hydrochlorothiazide
NITRATE/VASODILATOR
DIRECT RENIN INHIBITORS
indapamide
COMBINATIONS
ZAROXOLYN
DIRECT RENIN INHIBITOR
Diuretic Combinations
PULMONARY ARTERIAL
COMBINATIONS
amiloride/hydrochlorothiazide
HYPERTENSION
Endothelin Receptor Antagonists
ALDACTAZIDE
DIURETICS
Carbonic Anhydrase Inhibitors
NITRATES
Phosphodiesterase Inhibitors
acetazolamide
methazolamide
isosorbide dinitrate ext-rel tabs
DIAMOX SEQUELS
Prostaglandin Vasodilators
Loop Diuretics
Sublingual
MISCELLANEOUS
NITROSTAT
Potassium-sparing Diuretics
hydralazine
Transdermal
methyldopa
amiloride
nitroglycerin transdermal
Thiazide and Thiazide-like Diuretics
NITRO-DUR
PROAMATINE
chlorthalidone
CENTRAL NERVOUS SYSTEM
Practice guidelines for psychiatric disorders are DILANTIN
available at: http://www.psych.org
ANTIANXIETY
MYSOLINE
Benzodiazepines
TEGRETOL
TEGRETOL-XR
ZARONTIN
Serotonin Norepinephrine Reuptake
ZONEGRAN
KLONOPIN
Inhibitors (SNRIs)*
*Indicates the proposed mechanism of action,
ANTIDEMENTIA
based on the American Psychiatric Association Summary of Treatment Recommendations.
Miscellaneous
fluvoxamine
RAZADYNE
RAZADYNE ER
ANAFRANIL
BUSPAR

Tricyclic Antidepressants (TCAs)
ANTIDEPRESSANTS
ANTICONVULSANTS
Although these agents are primarily indicated amitriptyline
Practice guidelines for the treatment of epilepsy approved for other indications, including bipolar are available at: http://www.aan.com
disorder, obsessive-compulsive disorder, panic NORPRAMIN
disorder, and premenstrual dysphoric disorder.
phenobarbital
Guidelines for the evaluation and management TOFRANIL
DEPAKOTE
available at: http://www.psych.org
Miscellaneous Agents
DEPAKOTE ER
Monoamine Oxidase Inhibitors (MAOIs)
trazodone
LAMICTAL
WELLBUTRIN
WELLBUTRIN SR
NEURONTIN
Selective Serotonin Reuptake Inhibitors
WELLBUTRIN XL
TRILEPTAL
ANTIPARKINSONIAN AGENTS
Practice guidelines for the diagnosis and treatment of Parkinson's disease are available DEPAKENE
at: http://www.aan.com
amantadine
LITHOBID
benztropine
trihexyphenidyl
MULTIPLE SCLEROSIS AGENTS
Practice guidelines for multiple sclerosis are available at: http://www.aan.com
DEXEDRINE
DEXEDRINE SPANSULE
METADATE ER
MUSCULOSKELETAL THERAPY
APOKYN
ELDEPRYL
HYPNOTICS
Practice parameters for the treatment of sleep baclofen
PARLODEL
orphenadrine/aspirin/caffeine
http://www.aasmnet.org
SINEMET CR
Benzodiazepines
DANTRIUM
FLEXERIL
ANTIPSYCHOTICS
PARAFON FORTE DSC
Atypicals
RESTORIL
ROBAXIN
SKELAXIN
Nonbenzodiazepines
ZANAFLEX tabs
MYASTHENIA GRAVIS
RISPERDAL
MESTINON
MIGRAINE
NARCOLEPSY/CATAPLEXY
Guidelines for prevention and management of CLOZARIL
http://www.aan.com
Miscellaneous
Ergotamine Derivatives
chlorpromazine
CAFERGOT
PSYCHOTHERAPEUTIC-
fluphenazine
MISCELLANEOUS
haloperidol
D.H.E. 45
Alcohol Deterrents
perphenazine
thioridazine
trifluoperazine
Selective Serotonin Agonists
Narcotic Antagonists
ATTENTION DEFICIT HYPERACTIVITY
DISORDER
Guidelines for the evaluation and management Smoking Deterrents
of attention deficit disorder are available at: http://www.aacap.org
http://www.aap.org

nicotine transdermal
MOOD STABILIZERS
lithium carbonate
lithium carbonate ext-rel tabs 450 mg
ENDOCRINE AND METABOLIC
ANDROGENS
METAGLIP
Clinical practice guidelines for the treatment of Dipeptidyl Peptidase-4 (DPP-4)
http://www.aace.com
Amylin Analogs
Inhibitors
Biguanides
Dipeptidyl Peptidase-4 (DPP-4)
Inhibitor/Biguanide Combinations
ANTIDIABETICS
GLUCOPHAGE
Guidelines of treatment and management of GLUCOPHAGE XR
Incretin Mimetic Agents
http://www.diabetes.org
Biguanide/Sulfonylurea Combinations
Alpha-glucosidase Inhibitors
Insulins
Guidelines of treatment and management of http://www.aace.com
CYCLESSA
http://www.nof.org
ORTHO TRI-CYCLEN
ORTHO-NOVUM 7/7/7
HUMULIN 50/50 OTC
TRI-LEVLEN
HUMULIN 70/30 OTC
TRI-NORINYL
HUMULIN N OTC
HUMULIN R OTC
Extended Cycle
Calcitonins
NOVOLIN 70/30 OTC
NOVOLIN N OTC
calcitonin-salmon - Fortical
SEASONALE
NOVOLIN R OTC
MIACALCIN
Continuous
Parathyroid Hormones
Insulin Sensitizers
Progestin Only
CONTRACEPTIVES
NOR-QD
ORTHO MICRONOR

Insulin Sensitizer/Biguanide
Combinations
Monophasic
Emergency Contraception
20 mcg Estrogen
Insulin Sensitizer/Sulfonylurea
Injectable
Combinations
LOESTRIN 1/20
DEPO-PROVERA
LOESTRIN FE 1/20
Progestin Intrauterine Device
30 mcg Estrogen
Meglitinides
levonorgestrel/EE 0.15/30 - Levora
norgestrel/EE 0.3/30 - Low-Ogestrel
Transdermal
Sulfonylureas
LOESTRIN 1.5/30
LOESTRIN FE 1.5/30
GLUCOTROL
ORTHO-CEPT
GLUCOTROL XL
Supplies
35 mcg Estrogen
ENDOMETRIOSIS
ACCU-CHEK kits and test strips OTC
ethynodiol diacetate/EE 1/35 - Zovia
ASCENSIA kits and test strips OTC
BD insulin syringes and needles OTC
LANCETS OTC
BREVICON
ONETOUCH kits and test strips OTC
ESTROGENS
ANTIOBESITY
NORINYL 1+35
Guidelines of treatment and management of Guidelines of treatment and management of ORTHO-CYCLEN
hormone therapy and menopause are available obesity are available at: http://www.aace.com
ORTHO-NOVUM 1/35
at: http://www.menopause.org
http://www.nhlbi.nih.gov/guidelines/obesity/
ob_home.htm
50 mcg Estrogen
Monoamine Reuptake Inhibitors
ethynodiol diacetate/EE 1/50 - Zovia
Fat Absorption Decreasing Agents
NORINYL 1+50
ORTHO-NOVUM 1/50
Transdermal
CALCIUM RECEPTOR
Biphasic
ANTAGONISTS
MIRCETTE
Triphasic
CALCIUM REGULATORS
Bisphosphonates
levonorgestrel/EE - Trivora
prednisone
PROGESTINS
PEDIAPRED
ESTROGEN/PROGESTINS
AYGESTIN
GLUCOSE ELEVATING AGENTS
estradiol/norethindrone
SELECTIVE ESTROGEN
RECEPTOR MODULATORS
HUMAN GROWTH HORMONES
THYROID AGENTS
available at: http://www.aace.com
Antithyroid Agents
Transdermal
propylthiouracil
NORDITROPIN ##
NUTROPIN/NUTROPIN AQ ##
TAPAZOLE
SAIZEN ##
Thyroid Supplements
FERTILITY REGULATORS
HYPERPARATHYROID
levothyroxine
TREATMENT, VITAMIN D
levothyroxine - Levoxyl
chorionic gonadotropin - Novarel
SYNTHROID
VASOPRESSINS
PHENYLKETONURIA TREATMENT
MISCELLANEOUS
GLUCOCORTICOIDS
PHOSPHATE BINDER AGENTS
CARNITOR
DOSTINEX
dexamethasone
fludrocortisone
GASTROINTESTINAL
Guidelines for the treatment and management of various gastrointestinal diseases/conditions AZULFIDINE
are available at: http://www.acg.gi.org
AZULFIDINE EN-TABS
http://www.gastro.org
LEVSINEX
ANTIDIARRHEALS
Rectal Agents
loperamide
CHOLELITHOLYTICS
hydrocortisone enema
ANTIEMETICS
ACTIGALL
prochlorperazine
H2-RECEPTOR ANTAGONISTS
promethazine
LAXATIVES
lactulose
ANTIVERT
INFLAMMATORY BOWEL DISEASE
Injectable Agents
NULYTELY
TIGAN caps
Oral Agents
ANTISPASMODICS
PANCREATIC ENZYMES
chlordiazepoxide/clidinium
PROCTOCREAM-HC 2.5%
PRILOSEC
ULCER THERAPY COMBINATIONS
PROSTAGLANDINS
SALIVA STIMULANTS
PROTON PUMP INHIBITORS
MISCELLANEOUS
pantoprazole delayed-rel
STEROIDS, RECTAL
GENITOURINARY
BENIGN PROSTATIC
VAGINAL ANTI-INFECTIVES
HYPERPLASIA
Phosphodiesterase Inhibitors
METROGEL-VAGINAL
available at: http://www.auanet.org/guidelines
URINARY ANTISPASMODICS
TERAZOL 3
TERAZOL 7
MISCELLANEOUS
ERECTILE DYSFUNCTION
Guidelines for the management of erectile UROCIT-K
http://www.auanet.org/guidelines
Alprostadil Agents
PYRIDIUM
DITROPAN
URECHOLINE
DITROPAN XL
HEMATOLOGIC
Guidelines of treatment and management of HEMATOPOIETIC GROWTH
PLATELET AGGREGATION
http://www.hemophilia.org
Guidelines for the management of neutropenia INHIBITORS
ANTICOAGULANTS
are available at: http://www.asco.org
Injectable
associated with chronic kidney disease are http://www.kidney.org/professionals/kdoqi/g
PERSANTINE
uidelines.cfm
PLATELET SYNTHESIS
INHIBITORS
COUMADIN
Synthetic Heparinoid-like Agents
PAROXYSMAL NOCTURNAL
MISCELLANEOUS
HEMOGLOBINURIA (PNH) AGENTS
IMMUNOLOGIC AGENTS
DISEASE-MODIFYING
ANTIRHEUMATIC DRUGS
(DMARDs)
PLAQUENIL
Guidelines for the management of rheumatic IMMUNOSUPPRESSANTS
IMMUNOMODULATORS
Antimetabolites
http://www.rheumatology.org
methotrexate
http://www.cdc.gov/ncidod/diseases/hepatiti
s/index.htm
Guidelines for the management of hepatitis are available at: http://www.aasld.org
Interferons
Calcineurin Inhibitors
SANDIMMUNE
Rapamycin Derivatives
NUTRITIONAL/SUPPLEMENTS
Guidelines for recommended dietary intakes for VITAFOL-PN
http://www.nal.usda.gov/fnic/etext/000105.ht
Miscellaneous
Prenatal Vitamins
ELECTROLYTES
cyanocobalamin inj
Potassium
vitamin ADC/fluoride drops
vitamin ADC/fluoride/iron drops
potassium chloride liquid
CITRANATAL RX
LURIDE LOZI-TABS
VITAMINS AND MINERALS
POLY-VI-FLOR
ROCALTROL
Folic Acid Agents
folic acid
VITAFOL-OB
RESPIRATORY
Guidelines to the management, prevention, or ANTIHISTAMINE/DECONGESTANT
treatment of COPD and asthma are available at: COMBINATIONS
http://www.aaaai.org
http://www.nhlbi.nih.gov
http://www.goldcopd.com
brompheniramine/pseudoephedrine 4
http://www.ginasthma.com
mg/45 mg per 5 mL
brompheniramine/pseudoephedrine ext-
PROVENTIL
allergyrelated conditions are available at: rel 12 mg/120 mg
PROVENTIL soln
http://www.aaaai.org
brompheniramine/pseudoephedrine ext-
rel 6 mg/60 mg
ANAPHYLAXIS TREATMENT
Long Acting
DECONAMINE SR
ANTICHOLINERGICS
Oral Agents
ZYRTEC-D 12 Hour OTC
ipratropium soln
ANTITUSSIVES
albuterol
VOSPIRE ER
TESSALON
BRETHINE
ANTITUSSIVE COMBINATIONS
Narcotic

ANTICHOLINERGIC/BETA
CYSTIC FIBROSIS
AGONIST COMBINATIONS
codeine/chlorpheniramine/pseudoephe
codeine/guaifenesin liquid
codeine/guaifenesin/pseudoephedrine
LEUKOTRIENE RECEPTOR
codeine/promethazine
ANTAGONISTS
ANTIHISTAMINES, LOW SEDATING
PROMETHAZINE VC w/CODEINE
XYZAL
ZYRTEC OTC
MAST CELL STABILIZERS
Non-narcotic
ANTIHISTAMINES, NONSEDATING
dextromethorphan/brompheniramine/ps
eudoephedrine
INTAL soln
dextromethorphan/promethazine
ANTIHISTAMINES, SEDATING
NASAL ANTIHISTAMINES
clemastine 2.68 mg
BETA AGONISTS
cyproheptadine
Inhalants
hydroxyzine HCl
Short Acting
NASAL STEROIDS
flunisolide spray
XANTHINES
theophylline ext-rel tabs
STEROID INHALANTS
MISCELLANEOUS
STEROID/BETA AGONIST
ATROVENT spray
COMBINATIONS
DERMATOLOGY
Antipsoriatics
Guidelines for care of dermatological conditions Very High Potency
http://www.aad.org/professionals/guidelines/
diflorasone diacetate oint 0.05%
Guidelines for the care and treatment of acne vulgaris are available at: http://www.aad.org
DIPROLENE gel, oint
Oral
ACCUTANE
Antiseborrheics
TEMOVATE
ULTRAVATE
Topical
NIZORAL SHAMPOO
erythromycin soln
Emollients
sulfacetamide/sulfur crm, gel, lotion,
Corticosteroids
Guidelines of care for the use of topical LAC-HYDRIN
tretinoin (generic of AVITA)
http://www.aad.org
Immunomodulators
Low Potency
Guidelines for the treatment of atopic dermatitis are available at: http://www.aad.org
fluocinolone acetonide soln 0.01%
hydrocortisone lotion 1%
ACLOVATE
Local Analgesics
BENZAC AC
BENZAMYCIN
CLEOCIN T
Medium Potency
Local Anesthetic
betamethasone valerate crm, lotion,
oint 0.1%
desoximetasone crm 0.05%
Actinic Keratosis
fluocinolone acetonide crm, oint 0.025%
metronidazole gel 0.75%
CUTIVATE
Antibiotics
KENALOG 0.025%
gentamicin
KENALOG 0.1%
METROCREAM
BACTROBAN
METROLOTION
WESTCORT
SILVADENE
High Potency
Scabicides and Pediculicides
Antifungals
betamethasone dipropionate crm,
clotrimazole
lotion, oint 0.05%
econazole
diflorasone diacetate crm 0.05%
DIPROLENE AF
DIPROLENE lotion
Miscellaneous Skin and Mucous
KENALOG 0.5%
Membrane
MYCOSTATIN
PSORCON E crm
CONDYLOX
PSORCON E oint
TOPICORT
Immunomodulators
MOUTH/THROAT/DENTAL AGENTS
CORTISPORIN
Anesthetics - Topical Oral
MAXITROL
XYLOCAINE VISCOUS
Anti-inflammatories
Parasympathomimetics
Nonsteroidal
Steroids - Mouth/Throat
ISOPTO CARPINE
KENALOG IN ORABASE
Prostaglandins
OPHTHALMIC
VOLTAREN
Preferred Practice Pattern Guidelines for the Steroidal
http://www.aao.org/education/guidelines/ppp
/index.cfm
dexamethasone sodium phosphate
Sympathomimetics
Antiallergics
prednisolone phosphate 1%
brimonidine 0.2%
Sympathomimetic/Beta-blocker
PRED FORTE
Combinations
Antivirals
ZADITOR OTC
VIROPTIC
OTIC
Clinical practice guidelines for the treatment of
Anti-infectives
Beta-blockers
Nonselective
http://www.aap.org
bacitracin
Anti-infectives
erythromycin
gentamicin
acetic acid
polymyxin B/bacitracin
OPTIPRANOLOL
FLOXIN OTIC
TIMOPTIC
TIMOPTIC-XE
DOMEBORO OTIC
Selective
Anti-infective/Anti-inflammatory
BLEPH-10
Combinations
NEOSPORIN
acetic acid/hydrocortisone
Carbonic Anhydrase Inhibitors
POLYTRIM
Topical
Anti-infective/Anti-inflammatory
Combinations
CORTISPORIN OTIC
sulfacetamide/prednisolone
Miscellaneous
Carbonic Anhydrase Inhibitor/Beta-
phosphate10%/0.25%
blocker Combinations

Source: https://mrhcok.com/userfiles/File/April_2009_Detailed_Formulary.pdf

yad-mordechai.co.il

Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents Ian M. Paul, MD, MSc; Jessica Beiler, MPH; Amyee McMonagle, RN;Michele L. Shaffer, PhD; Laura Duda, MD; Cheston M. Berlin Jr, MD Objectives: To compare the effects of a single noctur- Main Outcome Measures: Cough frequency, cough nal dose of buckwheat honey or

infidar.ch

«Investoren zollen Novartis zu wenig Respekt» Die Performance der Novartis-Titel ist eine der schwächsten der Branche. Zu Unrecht, schreibt ein bekanntes US-Anlegermagazin und stellt sich damit gegen die meisten Analysten. Novartis habe den besten Geschäftsmix unter den grossen Pharma-Unternehmen und einer der stärksten Profit-Ausblicke, schreibt dieDiese Aussage steht quer in der Lan

Copyright © 2010-2014 Find Medical Article